Clinical and Laboratory Applied Regulatory Science
Closed Solicitation Posted
- Solicitation number
- FDA-RFP-19-1208111
- Agency
- FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Not on record
- Place of performance
- The US Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, Maryland 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration seeks clinical and laboratory applied regulatory science services through an indefinite delivery, indefinite quantity contract with a ceiling of $30 million over five years. The contractor must be capable of providing phase I clinical trial operations including protocol development, execution, and reporting, as well as bioanalytical methods, biomarker analyses, and final reporting for laboratory services. Proposals will be evaluated on technical qualifications, past performance, and price, with the award going to the offeror presenting the best value. The deadline for submission of proposals is July 17, 2019.
There is no set-aside designation for this procurement. The primary NAICS code is 541715 and PSC code R425. Performance will take place at 10903 New Hampshire Ave. in Silver Spring, Maryland. Security requirements are moderate for all contract objectives. The contractor must also comply with regulations regarding information security, personnel screening, and incident response.
Notice text
Clinical and Laboratory Applied Regulatory Science
.
Attachments
| File | Type | Posted |
|---|---|---|
| FDA-RFP-19-1208111_61719.pdf | ||
| FDA-RFP-19-1208111_61719.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity